Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212707
Company: MIKART
Company: MIKART
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
METHOCARBAMOL | METHOCARBAMOL | 1GM | TABLET;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/12/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
METHOCARBAMOL
TABLET;ORAL; 1GM
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
METHOCARBAMOL | METHOCARBAMOL | 1GM | TABLET;ORAL | Prescription | No | AB | 200958 | HANGZHOU BINJIANG |
METHOCARBAMOL | METHOCARBAMOL | 1GM | TABLET;ORAL | Prescription | No | AB | 212707 | MIKART |